Health Technology
Beyond Clean | September 07, 2023
Two prominent entities in the sterile processing industry, Crothall Healthcare and Beyond Clean, have entered into a strategic partnership to develop an innovative educational curriculum specially designed for sterile processing professionals serving in hospitals throughout the United States.
This partnership leverages both organizations' collective wealth of knowledge and extensive experience to empower sterile processing professionals with state-of-the-art expertise, enhance patient safety, and elevate the overall benchmarks for sterile processing industry-wide.
Afif Escheik, BA, CHL, CER, CIS, CRCST, CST, Regional Director of Operations at Crothall Healthcare, expressed that this partnership will enhance the company's capacity to provide sterile processing professionals with the educational tools necessary to meet and exceed industry standards, reduce errors, and optimize productivity.
Crothall's track record of achievement in the field of sterile processing has been founded upon its stringent, data-centric methodologies, which have led to a remarkable enhancement in audit compliance of nearly 90%, a substantial reduction in process errors of up to 50%, and significant productivity gains of up to 62%. Through this collaboration, Crothall intends to incorporate these invaluable insights into developing the forthcoming curriculum.
Hank Balch, Founder and President of Beyond Clean, remarked that this partnership will help elevate the standard of sterile processing in the United States, significantly impacting patient safety and quality of service.
The collaborative curriculum is adaptable for various care settings, promoting sustainable, high-value care, enhancing patient safety, and reducing errors across the healthcare organization. This partnership signifies a significant step towards a safer and more efficient future in surgical services.
About Crothall Healthcare
With more than three decades of experience in the healthcare sector, Crothall Healthcare is the foremost provider of patient-centered support services, offering comprehensive solutions tailored to diverse care settings. Its sterile processing services integrate extensive healthcare expertise, clinical rigor, and industry best practices to deliver efficient and highly effective services.
About Beyond Clean
Beyond Clean is a global expert in sterilizing educational content. The company's unwavering commitment to sterile processing motivates it to empower frontline professionals with essential knowledge, education, and steadfast assistance. It also enables them to uphold impeccable standards and ensure the continuous cleanliness of all instruments.
Read More
Healthcare Analytics
Business Wire | October 04, 2023
AirLife, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care formerly known as SunMed, today announced the completion of its acquisition of Avanos Medical, Inc.’s (NYSE: AVNS) (“Avanos”) respiratory health business, including the BALLARD*, MICROCUFF* and endOclear® product lines.
The acquisition adds three complementary brands, the R&D expertise behind them and two manufacturing facilities into AirLife’s growing platform. The transaction advances AirLife’s strategy to enhance its leading portfolio of the most trusted products in anesthesia and respiratory care and serve even more customers as a one-stop source for the highest-quality consumable breathing solutions that support the best patient outcomes.
“We’re thrilled to complete this exciting milestone in AirLife’s evolution as we strengthen our leadership as a premier, completely dedicated consumable breathing products company,”
said Hank Struik, AirLife CEO.
We are especially pleased to welcome the exceptional team that has driven the success of these market leading brands to our company. As some of the most trusted closed suction and endotracheal consumables used to treat patients in critical care, this addition to AirLife unlocks new opportunities to accelerate our growth, serve more healthcare practitioners and drive innovation across our comprehensive portfolio of leading brands.
[Source – Business Wire]
Goodwin Procter LLP is acting as legal counsel to AirLife.
About AirLife
AirLife, formerly known as SunMed and headquartered in Grand Rapids, Michigan with manufacturing and distribution sites in the United States, Mexico, China and Europe, is a leading medical device manufacturer, offering one of the most comprehensive portfolios of consumable anesthesia and respiratory care products. AirLife’s product portfolio spans the continuum of care from first responders to hospitals and home care, with safety, patient comfort and clinical performance in mind. AirLife’s comprehensive portfolio of trusted anesthesia products and respiratory care include premier brands such as Salter Labs®, Ethox Medical™, Ventlab™, Westmed™, AirLife™ and Vital Signs™. Currently, AirLife has over 1 million square feet of manufacturing space, providing comprehensive expertise in all plastics materials and conversion—supported by a world-class Quality Management System. Frazier Healthcare Partners, a leading healthcare investment firm, acquired a majority ownership stake in AirLife in 2021.
Read More
Health Technology, AI
Aidoc | October 12, 2023
Aidoc, a pioneer in clinical AI technology, has entered into a collaborative partnership with Mayo Clinic Platform to enhance healthcare by facilitating access to Aidoc's AI technology and platform.
Aidoc uses AI to help medical teams in charge of diagnosing, caring for, and treating patients stay in touch with each other. This ensures that essential data is always available to make smart decisions about healthcare interventions and what to do next.
Ed Simcox, Vice President of Solutions at Mayo Clinic Platform, confirmed that Aidoc is well-positioned to deal with several common issues with AI-based healthcare solutions, such as the costs of implementing them only once. By eliminating these barriers, healthcare providers of varying scales can readily implement AI, promoting improved patient outcomes and enhancing the overall care experience.
Elad Walach, Aidoc's CEO, said,
We're excited about Mayo Clinic Platform's vision to transform care at scale. Together we are improving clinical workflows, enhancing patient outcomes and driving the evolution of healthcare through the power of AI.
[Source – Cision PR Newswire]
Mayo Clinic has integrated Aidoc's innovative AI solutions for clinical decision support since 2020. Its collaboration with Mayo Clinic Platform is expanding access to these advanced tools for a broader range of healthcare providers and patients. Aidoc's offerings encompass 13 FDA-cleared image and partner algorithms, facilitating the prioritization of clinical findings. It also has a built-in risk stratification system, a mobile app for real-time notifications in time-sensitive cases, and seamless integration of EHR data, which makes it easier for people from different departments to talk to each other and coordinate care.
Aidoc's aiOS system confronts prevalent issues integrating artificial intelligence within practical healthcare environments. These challenges encompass the management of unstructured data, the efficient utilization of staff resources, the quantification of return on investment, and the resolution of fragmented organizational structures.
About Aidoc
Aidoc is a pioneering force in clinical AI, focusing on aiding and empowering healthcare teams to optimize patient treatment, resulting in improved economic value and clinical outcomes. Aidoc's proprietary aiOS builds the foundation for analyzing and aggregating medical data, enabling care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (13) in clinical AI, and its AI-based solutions cover 75% of patient populations, enabling physicians to make informed decisions based on real-time data.
Read More
Health Technology
Business Wire | November 02, 2023
Absolute Software™, the leading provider of self-healing, intelligent security solutions, today announced the launch of Absolute Application Health. This new feature empowers digital enterprises to strengthen cyber resilience and boost end user productivity with the industry’s most resilient application health monitoring capabilities. With this latest innovation to the company’s Secure Endpoint product line, customers can monitor the health of more than 2,000 commonly used Windows and Mac applications – including security controls, business, and productivity tools – to ensure they are installed, running, and properly configured on all devices.
“Organizations deploy millions of endpoint devices to support growing remote workforces around the world, and they invest billions of dollars into security controls needed to protect their networks against advanced threats and costly compliance violations,” said Sarah Pavlak, Industry Principal, Frost & Sullivan. “Despite all these efforts and money spent, organizations continue to experience increasing attacks and complexity challenges that severely disrupt business operations. This is leading to a continual need for innovations that can mitigate software failures and close security gaps.”
Absolute’s 2023 Resilience Index reveals that on average, enterprise endpoint devices have 67 applications deployed, with 10 percent of these having more than 100 applications installed. In analyzing 10 of the most widely deployed security tools, the report also shows seven of those 10 apps were installed and healthy on less than 80 percent of deployed devices, on average. In some cases, apps were only functioning correctly 47 percent of the time.
said John Herrema, Chief Product Officer, Absolute Software.
Today’s digital enterprises are investing billions of dollars in mission-critical security and business tools, and we believe those applications should deliver their intended value. The complexity and fragility of endpoint applications, however, means that all too often they are failing. And if the tool you use to monitor your other applications is subject to those same failures, then you’re really in trouble, because it’s impossible to fix what you can’t reliably see or diagnose. This latest innovation builds on Absolute’s unique Persistence technology to provide the industry’s most resilient visibility and monitoring capabilities. This allows our customers to achieve maximum security, productivity, and return on their software investments.
[Source:Business Wire]
With Absolute Application Health, IT and security practitioners gain the deep visibility needed to ensure applications are installed, running, up-to-date, and properly configured across their entire device fleet. They also have access to detailed, interactive reports and widgets that enable them to swiftly diagnose why an application is failing and then take remedial action.
Embedded in the firmware of more than 600 million devices, Absolute’s patented Persistence® technology provides a secure, always-on connection between the Absolute Platform and the endpoint. The new Application Health feature leverages this digital tether to ensure health monitoring and reporting remains uninterrupted.
Absolute Application Health is available now to Absolute Secure Endpoint customers subscribed to eligible Absolute Resilience licenses. For more information, including how to access and activate this new feature, visit our latest blog.
About Absolute Software
Absolute Software makes security work. We empower mission-critical performance with advanced cyber resilience. Embedded in more than 600 million devices, our cyber resilience platform delivers endpoint-to-network access security coverage, ensures automated security compliance, and enables operational continuity. Nearly 21,000 global customers trust Absolute to protect enterprise assets, fortify security and business applications, and provide a frictionless, always-on user experience.
Read More